Abstract: PO2289
Estimated Glomerular Filtration Rate (eGFR) and Myocardial Fibrosis Biomarkers in Hypertensives with and Without CKD
Session Information
- CKD: Drugs, Diet, and Other Determinants
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Authors
- Watanabe, Shota, University Hospitals, Cleveland, Ohio, United States
- Chen, Zhengyi, Case Western Reserve University, Cleveland, Ohio, United States
- Tatsuoka, Curtis, Case Western Reserve University, Cleveland, Ohio, United States
- Rahman, Mahboob, University Hospitals, Cleveland, Ohio, United States
- Wright, Jackson T., University Hospitals, Cleveland, Ohio, United States
- Dobre, Mirela A., University Hospitals, Cleveland, Ohio, United States
Background
CKD leads to accumulation of fibrotic tissue in the myocardium with subsequent loss of cardiac function. Two circulating biomarkers of collagen type I and III (PICP and P3NP) correlate with the amount of cardiac collagen deposition. Galectin 3 (Gal-3), a predictor of heart failure, is used to stratify patients at increased cardiovascular risk. We aimed to assess the association between eGFR and Gal-3, PICP, and PIIINP levels in individuals with and without CKD enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT).
Methods
A random sample of 1026 SPRINT participants 50 years or older were included in the study. Baseline demographic, anthropometric, co-morbid conditions and laboratory data were examined univariately for association with quartiles of Gal-3, CICP and PIIINP. The statistically significant variables were chosen for the multivariate quantile regressions at median (MQR) to assess the association between baseline eGFR and each biomarker.
Results
The mean age (SD) was 68.3±9.9 years, and 38.4% had CKD. In MQR models, baseline eGFR was negatively associated with Gal-3, PICP and PIIINP levels.(Figure) Similar results were found in participants with CKD, but not in participants without CKD, with significant correlation between eGFR with Gal 3 and PIIINP, but not with PICP. In combination, PIIINP was correlated with PICP (Coef 0.26, 95%CI (0.17, 0.35), p<0.001)), and Gal3 (Coef (0.35, 95%CI (0.26, 0.43), p<0.001) in the CKD subgroup, but not in the non-CKD subgroup (p=0.10, and p=0.07 respectively).
Conclusion
CKD status modifies the association between myocardial fibrosis biomarkers and eGFR, with high serum Gal-3, CICP, and PIIINP levels associated with low eGFR. Future research is needed to elucidate whether there is a causal link between kidney function decline and risk for myocardial fibrosis.
Quantile Regressions for eGFR and Myocardial Fibrosis Biomarkers
Funding
- Other NIH Support